Tafelmeier, Maria https://orcid.org/0000-0003-3778-6716
Malfertheiner, Maximilian
Zeman, Florian
Penzel, Thomas
Schoebel, Christoph
Randerath, Winfried
Treml, Marcel
Lotz, Gary
Pepin, Jean-Louis
Arzt, Michael
Funding for this research was provided by:
Universitätsklinikum Regensburg
Article History
Received: 3 April 2024
Revised: 20 December 2024
Accepted: 30 December 2024
First Online: 15 January 2025
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the four participating sleep centres in France and Germany - namely University Medical Centre Regensburg, Bethanien Hospital Solingen, Charité Berlin and University Medical Centre Grenoble Alpes - and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by each institution’s Research Ethics Committee.
: Informed consent was obtained from all individual participants included in the study.
: Michael Arzt received consulting and lecture fees from ResMed, Philips Respironics, NRI, Bresotec, Boehringer-Ingelheim, Novartis, JAZZ pharmaceuticals and Bayer. Michael Arzt is supported by Else-Kroener Fresenius Foundation (2018_A159). Maria Tafelmeier is supported by Else-Kroener-Foundation (2020_EKEA.25). Jean-Louis Pepin is supported by the French National Research Agency in the framework of the “Investissements d’avenir” program (ANR-15-IDEX-02) and the “e-health and integrated care and trajectories medicine and MIAI artificial intelligence” Chairs of excellence from the Grenoble Alpes University Foundation and MIAI @ university Grenoble Alpes (ANR-19-P3IA-0003).